ciclesonide
To investigate this, we studied the effects        of three doses of the novel corticosteroid ciclesonide (50 micrograms, 200       micrograms, and 800 micrograms) inhaled as a dry powder twice daily on airway       responsiveness to AMP and inflammatory parameters in induced sputum.
To investigate this, we studied the effects        of three doses of the novel  @OBJECT$  @PREDICAT$  @SUBJECT$  (50 micrograms, 200       micrograms, and 800 micrograms) inhaled as a dry powder twice daily on airway       responsiveness to AMP and inflammatory parameters in induced sputum.